13F-HR filed by Redmile Group, LLC
Redmile Group, LLC filed this 13F-HR for the quarter ended 2024-12-31, filed 2025-02-14, with 62 holding rows worth $1,434,861,498.
- Accession
- 0001104659-25-014154
- Filer
- CIK 1425738
- Filed
- 2025-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2024
A holdings report, 62 entries on the cover page, a total value of $1,434,861,498 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,434,861,498 with VALUE read as dollars as filed, 13F file number 028-12776. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SCHOLAR ROCK HLDG CORP | 80706P103 | COM | 4,549,881 | $196,645,857 | dollars as filed | |
| KRYSTAL BIOTECH INC COM | 501147102 | Stock | 753,175 | $117,992,396 | dollars as filed | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 4,192,627 | $78,989,093 | dollars as filed | |
| ZYMEWORKS INC | 98985Y108 | COM | 4,840,463 | $70,864,378 | dollars as filed | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 7,054,890 | $66,457,064 | dollars as filed | |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 4,905,527 | $59,405,932 | dollars as filed | |
| IMMUNOME INC | 45257U108 | COM | 4,828,026 | $51,273,636 | dollars as filed | |
| STOKE THERAPEUTICS INC | 86150R107 | COM | 4,593,629 | $50,667,728 | dollars as filed | |
| LIVANOVA PLC | G5509L101 | SHS | 1,043,539 | $48,326,291 | dollars as filed | |
| KYMERA THERAPEUTICS INC | 501575104 | COM | 1,100,432 | $44,270,379 | dollars as filed | |
| PLIANT THERAPEUTICS INC | 729139105 | COM | 2,895,478 | $38,133,445 | dollars as filed | |
| BEAM THERAPEUTICS INC | 07373V105 | COM | 1,528,567 | $37,908,462 | dollars as filed | |
| REGENXBIO INC | 75901B107 | COM | 4,794,780 | $37,063,649 | dollars as filed | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 1,235,209 | $34,363,514 | dollars as filed | |
| BIOHAVEN LTD | G1110E107 | COM | 904,496 | $33,782,926 | dollars as filed | |
| ANNEXON INC | 03589W102 | COM | 6,300,644 | $32,322,304 | dollars as filed | |
| ADC THERAPEUTICS SA | H0036K147 | COMMON STOCK | 15,666,731 | $31,176,795 | dollars as filed | |
| NEUROGENE INC | 64135M105 | COMMON STOCK | 1,319,763 | $30,169,782 | dollars as filed | |
| Boston Scientific Corporation | 101137107 | COM | 312,683 | $27,928,846 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 3,554,836 | $27,727,721 | dollars as filed | |
| ABSCI CORPORATION | 00091E109 | COM | 8,253,316 | $21,623,688 | dollars as filed | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 12,872,946 | $21,240,361 | dollars as filed | |
| IGM BIOSCIENCES INC | 449585108 | COM | 2,952,131 | $18,037,520 | dollars as filed | |
| 89BIO INC | 282559103 | COM | 2,167,176 | $16,947,316 | dollars as filed | |
| SILENCE THERAPEUTICS PLC | 82686Q101 | ADS | 2,399,317 | $16,507,301 | dollars as filed | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 619,300 | $15,916,010 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 615,775 | $15,560,634 | dollars as filed | |
| ESTABLISHMENT LABS HOLDINGS | G31249108 | COMMON STOCK | 320,149 | $14,749,264 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 571,824 | $14,164,080 | dollars as filed | |
| CERIBELL INC | 15678C102 | COMMON STOCK | 435,239 | $11,263,985 | dollars as filed | |
| Stryker Corporation | 863667101 | COM | 30,676 | $11,044,894 | dollars as filed | |
| RAPT THERAPEUTICS INC | 75382E109 | COM | 6,475,317 | $10,231,001 | dollars as filed | |
| BIONTECH SE SPONSORED ADS | 09075V102 | ADR | 83,471 | $9,511,520 | dollars as filed | |
| Intuitive Surgical,Inc. | 46120E602 | COM | 16,943 | $8,843,568 | dollars as filed | |
| KEROS THERAPEUTICS INC COM | 492327101 | Stock | 552,506 | $8,746,170 | dollars as filed | |
| NUVATION BIO INC COM CL A | 67080N101 | Stock | 3,031,009 | $8,062,484 | dollars as filed | |
| ARDELYX INC | 039697107 | COM | 1,576,259 | $7,991,633 | dollars as filed | |
| ORUKA THERAPEUTICS INC COM | 687604108 | Stock | 411,728 | $7,983,406 | dollars as filed | |
| VERVE THERAPEUTICS INC | 92539P101 | COM | 1,318,164 | $7,434,445 | dollars as filed | |
| SHATTUCK LABS INC | 82024L103 | COMMON STOCK | 5,539,724 | $6,703,066 | dollars as filed | |
| 4D MOLECULAR THERAPEUTICS INC COM | 35104E100 | Stock | 1,196,910 | $6,666,789 | dollars as filed | |
| ALX ONCOLOGY HOLDINGS INC | 00166B105 | COMMON STOCK | 3,689,611 | $6,161,650 | dollars as filed | |
| PENUMBRA INC COM | 70975L107 | Stock | 25,743 | $6,113,448 | dollars as filed | |
| PRIME MEDICINE INC | 74168J101 | COM | 2,074,350 | $6,057,102 | dollars as filed | |
| ATARA BIOTHERAPEUTICS INC | 046513206 | COM NEW | 441,701 | $5,879,040 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 92,598 | $4,355,810 | dollars as filed | |
| STEREOTAXIS INC | 85916J409 | COMMON STOCK | 1,799,465 | $4,102,780 | dollars as filed | |
| ALLAKOS INC | 01671P100 | COM | 3,015,097 | $3,648,267 | dollars as filed | |
| ASTRIA THERAPEUTICS INC COM | 04635X102 | Stock | 346,278 | $3,095,725 | dollars as filed | |
| AC IMMUNE SA | H00263105 | SHS | 1,034,299 | $2,792,607 | dollars as filed | |
| REPARE THERAPEUTICS INC | 760273102 | COM | 1,916,089 | $2,510,077 | dollars as filed | |
| INSULET CORP COM | 45784P101 | Stock | 9,559 | $2,495,568 | dollars as filed | |
| SOLID BIOSCIENCES INC | 83422E204 | COMMON STOCK | 615,246 | $2,460,984 | dollars as filed | |
| BOUNDLESS BIO INC | 10170A100 | COM | 740,204 | $2,146,592 | dollars as filed | |
| LAVA THERAPEUTICS NV | N51517105 | SHS | 2,074,372 | $1,972,728 | dollars as filed | |
| ACHILLES THERAPEUTICS PL-ADR | 00449L102 | COM | 1,608,089 | $1,833,221 | dollars as filed | |
| XERIS BIOPHARMA HOLDINGS INC | 98422E103 | COM | 451,099 | $1,529,226 | dollars as filed | |
| INVIVYD INC | 00534A102 | COMMON STOCK | 3,012,254 | $1,334,730 | dollars as filed | |
| ALLOVIR INC | 019818103 | COM | 1,907,969 | $801,347 | dollars as filed | |
| ADAPTIMMUNE THERAPEUTICS PLC | 00653A107 | SPONDS ADR | 715,607 | $385,497 | dollars as filed | |
| Ventyx Biosciences Inc | 92332V107 | Common Stock | 124,178 | $271,950 | dollars as filed | |
| HOOKIPA PHARMA INC | 43906K209 | COM NEW | 106,376 | $213,816 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001104659-25-014154 | this filing | 2025-02-14 | acceptance time not in the bulk data set |